Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS900672-enriched vs Follitropin Alfa in Ovulation Induction
NCT00553514Phase 2Terminated
- Sponsor
- Merck KGaA
- Start
- Dec 2007
- Primary completion
- Mar 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AS900672 in female infertility, sponsored by Merck KGaA. Started Dec 2007; status: terminated.
02
Drugs
AS900672
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT00553514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553514.